{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:30:45Z","timestamp":1787499045625,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ajpc.2024.100647","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T06:17:40Z","timestamp":1710137860000},"page":"100647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity"],"prefix":"10.1016","volume":"17","author":[{"given":"Ashish","family":"Sarraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi","family":"Dudum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Palaniappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5226-0723","authenticated-orcid":false,"given":"Fatima","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2024.100647_bib0001","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Simes R and Cholesterol Treatment Trialists C. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"139","key":"10.1016\/j.ajpc.2024.100647_bib0002","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"2019","author":"Grundy","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.ajpc.2024.100647_bib0003","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jacc.2022.02.048","article-title":"High-intensity statin use among patients with atherosclerosis in the U.S","volume":"79","author":"Nelson","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2024.100647_bib0004","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamacardio.2018.4936","article-title":"Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease","volume":"4","author":"Rodriguez","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2024.100647_bib0005","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamacardio.2018.1511","article-title":"Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use: insights from the patient and provider assessment of lipid management registry","volume":"3","author":"Nanna","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2024.100647_bib0006","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s11886-022-01736-y","article-title":"Health disparities across the continuum of ASCVD risk","volume":"24","author":"Devareddy","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ajpc.2024.100647_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/291954","article-title":"Racial and ethnic variation in lipoprotein (a) levels among Asian Indian and Chinese patients","volume":"2011","author":"Banerjee","year":"2011","journal-title":"J Lipids"},{"key":"10.1016\/j.ajpc.2024.100647_bib0008","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.113.005757","article-title":"Racial\/ethnic differences in dyslipidemia patterns","volume":"129","author":"Frank","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2024.100647_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124341","article-title":"Leading causes of death among Asian American subgroups (2003-2011)","volume":"10","author":"Hastings","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2024.100647_bib0010","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.jacc.2014.08.048","article-title":"Cardiovascular disease mortality in Asian Americans","volume":"64","author":"Jose","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2024.100647_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011874","article-title":"Atherosclerotic cardiovascular disease risk prediction in disaggregated asian and hispanic subgroups using electronic health records","volume":"8","author":"Rodriguez","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2024.100647_bib0012","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jamacardio.2016.4653","article-title":"Disaggregation of cause-specific cardiovascular disease mortality among hispanic subgroups","volume":"2","author":"Rodriguez","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2024.100647_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008651","article-title":"Cardiovascular and cerebrovascular disease mortality in Asian American subgroups","volume":"15","author":"Shah","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajpc.2024.100647_bib0014","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7326\/M23-0720","article-title":"Disparities in guideline-recommended statin use for prevention of atherosclerotic cardiovascular disease by race, ethnicity, and gender: a nationally representative cross-sectional analysis of adults in the United States","volume":"176","author":"Frank","year":"2023","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ajpc.2024.100647_bib0015","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.2021.9907","article-title":"Trends in differences in health status and health care access and affordability by race and ethnicity in the United States, 1999-2018","volume":"326","author":"Mahajan","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2024.100647_bib0016","article-title":"Cardiovascular disease mortality among hispanic versus non-hispanic white adults in the United States, 1999 to 2018","volume":"11","author":"Khan","year":"2022","journal-title":"Ja Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2024.100647_bib0017","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/MLR.0b013e3181d559e9","article-title":"Using name lists to infer Asian racial\/ethnic subgroups in the healthcare setting","volume":"48","author":"Wong","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.ajpc.2024.100647_bib0018","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American college of cardiology solution set oversight committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2024.100647_bib0019","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation."},{"key":"10.1016\/j.ajpc.2024.100647_bib0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/clc.23448","article-title":"Is race or ethnicity associated with under-utilization of statins among women in the United States: the study of women's health across the nation","volume":"43","author":"Jackson","year":"2020","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2024.100647_bib0021","doi-asserted-by":"crossref","first-page":"477","DOI":"10.18865\/ed.29.3.477","article-title":"Years of potential life lost from cardiovascular disease among hispanics","volume":"29","author":"Manjunath","year":"2019","journal-title":"Ethn Dis"},{"key":"10.1016\/j.ajpc.2024.100647_bib0022","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2105\/AJPH.2012.301103","article-title":"Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature","volume":"103","author":"Ruiz","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ajpc.2024.100647_bib0023","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pcad.2014.09.001","article-title":"The Hispanic paradox in cardiovascular disease and total mortality","volume":"57","author":"Medina-Inojosa","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ajpc.2024.100647_bib0024","doi-asserted-by":"crossref","first-page":"11812","DOI":"10.1038\/s41598-022-15916-x","article-title":"Trends in national and county-level Hispanic mortality in the United States, 2011-2020","volume":"12","author":"Sarraju","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpc.2024.100647_bib0025","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/CIRCULATIONAHA.121.054378","article-title":"Racial and ethnic disparities in heart and cerebrovascular disease deaths during the COVID-19 pandemic in the United States","volume":"143","author":"Wadhera","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2024.100647_bib0026","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000580","article-title":"Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association","volume":"138","author":"Volgman","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.ajpc.2024.100647_bib0027","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/CIRCULATIONAHA.117.032615","article-title":"High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): a randomized superiority trial","volume":"137","author":"Taguchi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2024.100647_bib0028","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s43856-022-00157-w","article-title":"Using deep learning-based natural language processing to identify reasons for statin nonuse in patients with atherosclerotic cardiovascular disease","volume":"2","author":"Sarraju","year":"2022","journal-title":"Commun Med (Lond)"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667724000151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667724000151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T07:38:51Z","timestamp":1711525131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667724000151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"alternative-id":["S2666667724000151"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2024.100647","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2024.100647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100647"}}